Obesity drugs aren’t always forever. Obesity drugs have another superpower: taming inflammationBut Christoffer Clemmensen, a metabolism specialist at the University of Copenhagen, saw a path forwards. This potential therapeutic, called OP-216, has the added benefit of also mimicking GIP in addition to GLP-1, Clemmensen says. Beyond Ozempic: brand-new obesity drugs will be cheaper and more effectiveThe success of the current crop of obesity drugs has set a high bar for next-generation therapeutics. Treating them with obesity drugs could confer wider health advantages, such as cardiovascular and anti-inflammatory benefits.

Source: Punch May 15, 2024 19:24 UTC